Ocular Therapeutix, Inc. $OCUL Shares Bought by Second Line Capital LLC
Second Line Capital LLC grew its holdings in Ocular Therapeutix, Inc. (NASDAQ:OCUL – Free Report) by 20.9% during the second quarter, HoldingsChannel.com reports. The fund owned 638,640 shares of the biopharmaceutical company’s stock after purchasing an additional 110,350 shares during the quarter. Ocular Therapeutix makes up about 1.1% of Second Line Capital LLC’s portfolio, making […]
8 Sep 09:29 · The Markets Daily